1. Purified Astragalus Polysaccharide Combined with Inactivated Vaccine Markedly Prevents Infectious Haematopoietic Necrosis Virus Infection in Rainbow Trout ( Oncorhynchus mykiss ).
- Author
-
Pan Y, Liu Z, Quan J, Gu W, Wang J, Zhao G, Lu J, and Wang J
- Subjects
- Animals, Adjuvants, Immunologic pharmacology, Adjuvants, Immunologic administration & dosage, Polysaccharides pharmacology, Polysaccharides administration & dosage, Infectious hematopoietic necrosis virus immunology, Vaccines, Inactivated immunology, Vaccines, Inactivated administration & dosage, Vaccines, Inactivated pharmacology, Oncorhynchus mykiss virology, Oncorhynchus mykiss immunology, Astragalus Plant chemistry, Fish Diseases prevention & control, Fish Diseases virology, Fish Diseases immunology, Viral Vaccines immunology, Viral Vaccines administration & dosage, Rhabdoviridae Infections prevention & control, Rhabdoviridae Infections veterinary, Rhabdoviridae Infections virology, Rhabdoviridae Infections immunology
- Abstract
Rainbow trout ( Oncorhynchus mykiss ) is experiencing a catastrophic pandemic. In recent years, infectious hematopoietic necrosis virus (IHNV) has spread nationwide, resulting in significant mortality. Currently, there are no available treatments or vaccines for IHNV in China. Here, the Astragalus extract was purified and characterized. Then, we developed an inactivated IHNV vaccine with purified Astragalus polysaccharide (P-APS) as an adjuvant. Safety assays showed that IHNV was successfully inactivated. After a serious IHNV challenge, the cumulative mortality rates were 76.0, 38.0, and 22.1% in control, vaccine, and P-APS + vaccine groups, respectively. P-APS + vaccine was effective at reducing head kidney damage and apoptosis after IHNV challenge by histopathological and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) analyses. The P-APS + vaccine group showed better results in enhancing specific antibodies (IgM) and immune enzyme activities (C3, LZM, GOT, and GPT). RNA-seq revealed that many immune-related pathways were significantly enriched. TLR2 , TLR7 , C3 , IFN-γ , IgM , MHC1 , MHC2 , MX1 , and VIG1 were identified as core genes based on RNA-seq and PPI networks. Mechanistic investigations showed that P-APS + vaccine activates the immune pathway by upregulating the expression of these genes. P-ASP+vaccine induced effective innate and adaptive immune responses that were stronger than single vaccines after vaccination and IHNV challenged. Our findings will provide a promising vaccine candidate against IHNV.
- Published
- 2024
- Full Text
- View/download PDF